What's new

RSS
Date Content
29/11/2019 Periodic safety update single assessment: Triamcinolone (intraocular formulations): List of nationally authorised medicinal products - PSUSA/00010292/201903
29/11/2019 Human medicines European public assessment report (EPAR): Udenyca, pegfilgrastim, Neutropenia, 21/09/2018, Additional monitoring, Biosimilar, 3, Authorised
29/11/2019 Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Stomach Neoplasms, Breast Neoplasms, 16/05/2018, Additional monitoring, Biosimilar, 6, Authorised
29/11/2019 Human medicines European public assessment report (EPAR): Senstend, lidocaine, prilocaine, Premature Ejaculation, 14/11/2019, Authorised
29/11/2019 Leaflet: World AIDS Day – Communities make the difference
29/11/2019 Other: Timetable: Periodic safety update report (PSUR) and PSUR single assessment (PSUSA) - Advanced therapy medicinal products (ATMPs)
29/11/2019 Other: Timetable: Periodic safety update report (PSUR) and PSUR single assessment (PSUSA)
29/11/2019 News and press releases: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 November 2019
29/11/2019 Paediatric Committee (PDCO): 25-28 June 2019 , European Medicines Agency, Amsterdam, The Netherlands, from 25/06/2019 to 28/06/2019
29/11/2019 Minutes: Minutes - PDCO minutes of the 25-28 June 2019 meeting
29/11/2019 Minutes: Minutes - PDCO minutes of the 27-29 May 2019 meeting
29/11/2019 Veterinary Medicines
29/11/2019 Other: Organisation chart: Veterinary Medicines
29/11/2019 Human medicines European public assessment report (EPAR): Neulasta, pegfilgrastim, Neutropenia, Cancer, 22/08/2002, 34, Authorised
29/11/2019 Committee meeting report: CAT monthly report of application procedures, guidelines and related documents on advanced therapies: November 2019
28/11/2019 News and press releases: ‘Regulatory science to 2025’: live broadcast of post-consultation workshop on veterinary medicines
28/11/2019 Agenda: Agenda - Multi-stakeholder workshop on draft 'Regulatory Science to 2025' strategy (stakeholders for veterinary medicines)
28/11/2019 Leaflet: EMA Regulatory Science to 2025 - Four goals for veterinary medicines regulation
28/11/2019 Periodic safety update single assessment: Cabergoline: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00000477/20190
28/11/2019 Periodic safety update single assessment: Cabergoline: List of nationally authorised medicinal products - PSUSA/00000477/201903
28/11/2019 Human medicines European public assessment report (EPAR): Fotivda, tivozanib, Carcinoma, Renal Cell, 24/08/2017, Additional monitoring, 4, Authorised
28/11/2019 Human medicines European public assessment report (EPAR): Rixathon, rituximab, Lymphoma, Non-Hodgkin, Arthritis, Rheumatoid, Leukemia, Lymphocytic, Chronic, B-Cell, Wegener Granulomatosis, Microscopic Polyangiitis, Pemphigus, 15/06/2017, Additional monitoring, Biosimilar, 3, Authorised
28/11/2019 Human medicines European public assessment report (EPAR): Toviaz, fesoterodine fumarate, Urinary Bladder, Overactive, 20/04/2007, 23, Authorised